Calamos Advisors’s Sarepta Therapeutics SRPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-15,016
Closed -$2.07M 1031
2023
Q1
$2.07M Buy
15,016
+4,302
+40% +$593K 0.01% 717
2022
Q4
$1.39M Buy
10,714
+1,724
+19% +$223K 0.01% 807
2022
Q3
$994K Buy
+8,990
New +$994K ﹤0.01% 912